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Abstract
Background: Continuous quality improvement (CQI) has been successfully applied in business and engineering for
over 60 years. While using CQI techniques within nephrology has received increased attention, little is known about
where, and with what measure of success, CQI can be attributed to improving outcomes within nephrology care.
This is particularly important as payors’ focus on value-based healthcare and reimbursement is tied to achieving
quality improvement thresholds. We conducted a systematic review of CQI applications in nephrology.
Methods: Studies were identified from PubMed, MEDLINE, Scopus, Web of Science, CINAHL, Google Scholar,
ProQuest Dissertation Abstracts and sources of grey literature (i.e., available in print/electronic format but not
controlled by commercial publishers) between January 1, 2004 and October 13, 2014. We developed a systematic
evaluation protocol and pre-defined criteria for review. All citations were reviewed by two reviewers with
disagreements resolved by consensus.
Results: We initially identified 468 publications; 40 were excluded as duplicates or not available/not in English. An
additional 352 did not meet criteria for full review due to: 1. Not meeting criteria for inclusion = 196 (e.g., reviews,
news articles, editorials) 2. Not nephrology-specific = 153, 3. Only available as abstracts = 3. Of 76 publications
meeting criteria for full review, the majority [45 (61%)] focused on ESRD care. 74% explicitly stated use of specific
CQI tools in their methods. The highest number of publications in a given year occurred in 2011 with 12 (16%)
articles. 89% of studies were found in biomedical and allied health journals and most studies were performed in
North America (52%). Only one was randomized and controlled although not blinded.
Conclusions: Despite calls for healthcare reform and funding to inspire innovative research, we found few high
quality studies either rigorously evaluating the use of CQI in nephrology or reporting best practices. More rigorous
research is needed to assess the mechanisms and attributes by which CQI impacts outcomes before there is further
promotion of its use for improvement and reimbursement purposes.
Keywords: Kidney disease, Continuous quality improvement, Systematic review
Background
The United States health care system is one of the most
expensive in the world, yet it ranks lowest among devel-
oped countries on many aspects of quality and perform-
ance [1–3]. Projections indicate there will be an epidemic
growth of many chronic diseases in the future, including
chronic kidney disease (CKD) [4]. Thus, identifying and
addressing barriers to the delivery of high-quality, low-
cost care is of paramount importance.
Continuous quality improvement (CQI) provides a
systematic way to identify and address barriers to better
outcomes. There is no single definition of CQI, but
generally it is a management technique and set of tools
to optimize systems and continually improve processes
[5, 6] (Table 1). CQI methods have been used in the
business and engineering sectors since the 1940’s and
adoption of these techniques preceded Japan’s rise as a
leading manufacturer post World War II [7].
More recently, CQI has been encouraged for use in
healthcare [8]. Healthcare systems often have specific
staff (i.e., quality officers) devoted to leading quality
improvement efforts [9]. CQI modules are integral in
* Correspondence: juwright@med.umich.edu
1Department of Internal Medicine, Division of Nephrology, University of
Michigan Health System, Ann Arbor, MI, USA
Full list of author information is available at the end of the article
© The Author(s). 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Nunes et al. BMC Nephrology  (2016) 17:190 
DOI 10.1186/s12882-016-0389-1
medical training [10] including core curriculums for resi-
dency and fellowship education. There are a number of
peer reviewed journals dedicated to publishing papers
about CQI in healthcare–either as a primary or secondary
focus of the journal (http://www.ihi.org/education/IHI
OpenSchool/resources/Pages/WhereToSubmitYourWriting
QIFriendlyPeerReviewedJournals.aspx) [11]. In addition,
a recent series of articles promoted use of quality im-
provement tools in nephrology practice [12–16].
Although there has been interest in applying CQI within
healthcare, and numerous reports of CQI processes that
have been applied in healthcare, there appears to be a
paucity of published literature systematically evaluating
CQI use and its impact within medical contexts [17]. Past
evaluations have been performed to assess effectiveness of
CQI in some chronic conditions, [18] but there is hetero-
geneity in what exactly has been evaluated and how evalu-
ations have been carried out [19]. This leaves some
question as to how to interpret current evidence on the
effectiveness of specific CQI strategies.
Over two decades ago, CQI was introduced and
promoted for end-stage nephrology care by CMS [20].
Subsequent improvements were reported both in care
patterns and clinical indices within U.S. dialysis popula-
tions [21–24]. But there is not yet a description on the
state of evidence-based quality improvement science in
the most recent time periods since, and across the con-
tinuum of nephrologic care. What quality tools have
been used and evaluated? Where and how have they
been successfully applied? Without having the answers
to these questions, we are left promoting and adopting
methods without fully understanding exactly how CQI
has been used, where successes have been seen and
whether changes observed are due to CQI itself or other
factors.
We conducted a systematic review of the published
literature to address these areas. The objectives of this
review were to assess the extent CQI has been utilized
in nephrology, identify temporal and/or spatial trends of
use, assess if outcomes have been associated with CQI
and determine which areas of nephrologic care have
been most amenable to improvement efforts.
Methods
With the aid of a professional informationist, we con-
ducted a systematic review of the literature regarding
quality improvement in nephrology.
To adhere to established best practices, we aligned our
review process with the “Preferred Reporting of Items
for Systematic Reviews and Meta-analyses” (PRISMA)
recommendations [25].
Protocol and eligibility
We defined our review to include full-text articles or
reports in English that utilized continuous quality
improvement to identify or address clinical, cost, effi-
ciency, safety, communication, or process issues within
nephrology. The search time-period was January 1, 2004
through October 1, 2014.
We considered research to be relevant if the CQI
activities had been applied to participants (e.g., patients,
providers), environmental issues, systems or processes.
Our definition of “CQI” included methods that use
quality improvement tools to (a) understand a process
or system of care, (b) generate theories for why prob-
lems exist, (c) dissect why process issues in care occur,
(d) choose best solutions to problems, (e) identify or
improve current flow, or (f ) institute remedies to fix
problems. To be included, articles had to contain a CQI
activity applied within an area of nephrology, e.g.,;
chronic kidney disease (CKD), acute kidney injury, end
stage renal disease (ESRD) or renal transplantation. Case
reports, clinical practice guidelines, “thought” pieces,
editorials, “state-of-affairs-reports”, literature reviews,
news reports and meta-analyses were excluded.
To assess the nature and quality of the CQI work
cited, articles were evaluated for whether a predefined
outcome was measured, whether there was a follow up
Table 1 Continuous Quality Improvement – Attributes and
Potential Associated Activities—adapted from Juran’s Quality
Handbook [6]
Attributes of continuous quality
improvement
Example(s) of associated activities
Highly team based and
multi-disciplinary
Bringing together staff from
management, administration,
and ‘front-lines’ to meet for
improvement goal
Understanding a process-either to
identify areas of improvement or








Generation and arranging of
theories for why problems exist
Tabulation methods
Cause/effect (Ishikawa) diagrams
Process dissection, a way of testing
why a process that is ‘capable’ isn’t
performing right
Testing at Intermediate stages
Stream-to-stream testing
Time-to-time analyses
Choosing best solutions for process
improvement or product design








Instituting remedies Plan, do, check, act
Nunes et al. BMC Nephrology  (2016) 17:190 Page 2 of 9
measurement post CQI activity, and if so, whether
improvement in an outcome was identified.
Information sources and search strategy
Studies were identified by searching electronic databases
and sources of gray literature. The literature search was
applied to PubMed MEDLINE, Scopus, Web of Science,
Cumulative Index of Nursing and Allied Health Literature
(CINAHL), Google Scholar, and ProQuest Dissertation
Abstracts. Pre-defined search algorithms were used to
query PubMed MEDLINE as one part of the literature re-
view and other databases as outlined above. Search terms
used in PubMed MEDLINE were: ((("Nephrology" [Mesh]
OR nephrology[tiab] OR renal[tiab] OR "Kidney Diseases"
[Mesh]))) AND ((("Total Quality Management" [MeSH
Terms] OR "Quality Improvement" [MeSH Terms] OR
"quality improvement"[tiab] OR "Six Sigma" [tiab] OR
"continuous quality improvement"[tiab] OR "total quality
management" [tiab] OR "root cause" [tiab] OR "value
stream" [tiab]))) NOT (Comment [ptyp] OR Editorial
[ptyp] OR Letter [ptyp]). Terms were adapted for specific
needs of each additional search engine.
Review team
An expert panel was convened for the review. This panel
included one member both with a doctorate in Instruc-
tional Technology and a Masters in Library and Infor-
mation Sciences (NM), four practicing nephrologists
who also had training in epidemiology and public health
(MH, PR, JHS, JWN), and one member with a doctorate
in psychology, who also oversees a patient safety and
quality scholars program for our health system (FJS).
Because definitions of CQI vary, several pre-review
meetings of this team were used to define the scope of
the review, define the questions we sought to answer
and to establish a consensus definition of CQI. From
these pre-review meetings we developed an initial
algorithm for the review (Fig. 1). Two rounds of piloting
the review process occurred whereby all members of the
review panel reviewed an initial set of 20 citations, and
subsequently met to discuss their independent reviews;
the purpose was to clarify questions that arose and
refine the review approach where needed. This served to
maximize transparency, and ensure consistency in the
reviews.
Study Selection and data abstraction
Two nephrologist reviewers evaluated the eligibility of
each citation independently using citation title and
abstract. One reviewer reviewed all citations (JWN) and
each citation was co-reviewed by an additional reviewer
(MH, JHS, or PR). Full text articles were retrieved for
any citation deemed potentially relevant. The reviewers
then met to review their independent evaluations of
inclusion with the final eligibility confirmed in this co-
review. Disagreements on inclusion were resolved by
consensus. Data abstraction occurred once a citation
was deemed to have met the eligibility criteria and
agreed upon by consensus for inclusion by the two inde-
pendent reviewers.
The team developed a set of characteristics that would
be used to define the nature of the CQI activity
described in each eligible study. Pre-defined forms for
data abstraction were used in assessing these studies.
Fields assessed included whether a specific CQI tool was
described and if so, which tool. We assessed which out-
comes were measured, the type of outcome, and whether
there was a comparison group or baseline measure that
showed improvement. We assessed the study trial type
including whether the study was randomized with a con-
trol group. Additional data included continent of origin,
year published, primary journal discipline, and area of
nephrology where CQI was applied.
Data analysis and reporting
Abstracted data was summarized as frequency (n) and
percent (%). Citations were managed using reference
Fig. 1 Algorithm for review. *Use of quality improvement with a
pre-defined methodology to identify or address clinical, cost, efficiency,
safety, communication or process issues within nephrology
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manager RefWorks (Copyright2015, Proquest LLC) and
Endnote X4 (Copyright 1988-2010, Thompson-Reuters).
Results
Figure 2 shows the flow of information through the
different phases of our review. The search identified 468
citations from January 1, 2004 through October 1, 2014.
After adjusting for duplicates, those not available in
English, and those with no abstract available in print or
online, we reviewed 428 citations. Of these, 153 were
not on a topic directly related to nephrology and 196 did
not meet criteria for inclusion (e.g., letters to editor,
reviews, no clear mention of any CQI as a purpose at
study outset, or no mention of CQI at all in methods).
Seventy-nine met criteria for full review; three were only
available in abstract form. Seventy-six were included in
final quantitative analyses (Fig. 2).
Characteristics of the included 76 studies are as
follows. Fifty-six (74%) explicitly provided mention of a
specific CQI tool in their methods (e.g., value stream
mapping, plan-do-check-act, root cause analysis or
multi-disciplinary teams). Sixty-eight (89%) were pub-
lished in biomedical and allied health journals. The
number of studies peaked in 2011, with 12 reported in
the literature (Fig. 3). Forty studies (52%) originated in
North America, followed by 23 (30%) from Europe, and
a total of 5 from Asia, 5 from Australia, 2 from South
America, and 1 from Africa.
The majority of studies focused on CQI use within
ESRD (61%), although there was overlap across sub-
disciplines within nephrology in nine of these. One study
spanned improvement efforts applicable to all of
nephrology. Figure 4 shows a breakdown of studies
within each nephrology sub-discipline (Fig. 4).
Table 2 summarizes by discipline the types of out-
comes measured, where CQI techniques were applied
and whether interdisciplinary teams were involved. Most
outcomes were clinical (e.g., 34 of the 46 studies in
ESRD or 74%). Explicit CQI techniques were most often
used to identify problems or causes to problems, rather
than focused on solutions to address them (Table 2).
In addition, four of the 76 studies were conducted
within pediatric nephrology [26–29]. One used statistical
process control to identify improvements in an interven-
tion to increase CRRT filter life [26]. Another attempted
to improve the pediatric dialysis experience using a
‘nursing intervention’- not well described [27]. Two
other studies focused on populations in CKD not on dia-
lysis– developing protocols for managing nephrotic syn-
drome [29] and improving patient satisfaction [28].
Forty-two out of the 76 studies (55%) reported both a
baseline or first-measured outcome and post measure
outcome along with improvement. Of these, 23 focused
on clinical outcomes, six were cost/efficiency related,
and 11 included outcomes both clinical and cost/
Fig. 2 PRISMA flow chart of our review
Fig. 3 Number of articles published, by year
Fig. 4 Breakdown of studies within each sub-discipline (note, some
studies may have spanned > 1 discipline e.g., Interventional and
ESRD, the primary discipline is shown)
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efficiency related. Following the trend of our overall
sample, the majority of these studies (27 of the 42, 64%)
occurred in end stage populations receiving hemo-
dialysis—focusing on improving clinical indices (fistula
rates/patency, anemia, high blood pressure). Some
spanned systems of care; for example, one study used
multi-disciplinary teams led by quality coaches to
reduce contrast induced acute kidney injury across six
hospitals [30].
Only one study of the 76 was randomized and
controlled. It was not blinded due to the nature of the
study [31]. Seventeen dialysis patients were randomized
to a home blood pressure monitor plus an education
intervention and 17 received usual care. Significant im-
provements in blood pressure were observed in the
intervention group. The intervention was nursing driven
and focused on home blood pressure monitoring to sup-
port patients in engaging in their own blood pressure
management [31].
A table that lists all 76 articles and key areas of
data we abstracted is located in the Additional file.
(Additional file 1).
Discussion
Despite calls for healthcare reform [8] and funding for
research promoting novel methods to improve care, [32]
our review revealed little rigorous research examining
impact or efficacy of CQI in nephrology. We identified
only 76 published studies in a 10 year span. The majority
of studies (66% including ESRD and interventional-
related studies) focused at end stages of renal disease,
missing an early opportunity to use CQI to optimize
processes to prevent or abate disease progression. When
applied, many CQI efforts used multi-disciplinary team-
work, not taking advantage of other well-developed
methods like statistical process control or plan-do-check-
act. Only slightly more than half of the studies included
pre- and post-intervention outcome measures. These find-
ings highlight a significant need for increased rigor in CQI
research and reporting in nephrology.
CQI methods have reportedly been applied to multi-
million (even billion) dollar industries outside of health-
care with considerable success. Boeing, a leading U.S.
aerospace corporation, reported a 54 % reduction in
build hours and 218 % increase in its build rate of heli-
copters during the 1990’s [33]. They reduced defects
90% while saving 1.5 million labor hours and halving de-
livery time of aircraft. CQI in healthcare has shown
promise as well, [34] highlighted in experiences at the
Virginia Mason Medical Center [35]. By adapting and
implementing the Toyota Production System of quality
improvement into its hospital and clinics, [36] teams
redesigned care to better meet patients’ needs, reduced
inefficiencies in nursing, and increased direct nursing
care activities [35]. Given these successes, it is unclear
why CQI has not been studies or reported on more
widely and rigorously within the nephrologic literature.
Medical literature ideally involves a high level of scru-
tiny prior to publication-including a peer-reviewed vetting
process and assurances that studies are designed to exam-
ine whether an intervention impacts outcomes. Perhaps
CQI research designs or interventions are not familiar














Baseline/one-time only 13 (28%) 6 (31%) 1 (20%) 1 (100%)
Pre/post outcome measures 29 (63%) 7 (37%) 1 (100%) 4 (80%) 3 (75%)
Unclear or no outcomes measured 4 (9%) 5 (26%) 1 (25%)
Type(s) of outcome(s)a
Clinical 34 (74%) 9 (47%) 1 (100%) 3 (60%) 2 (50%)
Cost/efficiency 14 (30%) 4 (21%) 1 (100%) 2 (40%) 1 (25%)
Explicit CQI technique(s) usedb
To identify problems 33 (72%) 15 (79%) 1 (100%) 5 (100%) 2 (50%)
To identify/address solutions 19 (41%) 7 (36%) 1 (100%) 4 (80%) 1 (25%) 1 (100%)
Use of interdisciplinary teams 28 (61%) 12 (63%) 1 (100%) 2 (40%) 3 (75%)
aNote: studies may have included more than one type of outcome
bNote: studies may have used CQI to identify problems and address solutions
ESRD references: [27, 31, 45–88]
CKD references: [28, 89–106]
Transplant reference: [107]
AKI references: [26, 30, 108–110]
Interventional nephrology references: [111–114]
Other (this study was aimed at nephrology discipline in general) reference: [115]
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enough to traditional journals or do not measure up to
rigors established for reporting [37]. It may also be that
applications of CQI in nephrology are intended to meet
internal needs of practices and not thought of as applicable
to publish. One example may be found in the ESRD net-
works: all networks engage in regular regional improve-
ment activities and routinely set out to achieve important
clinical goals using CQI toolkits, [38] but are not typically
designed for research publication. Although the study of
CQI implementation may not be thought of as traditional
research in the past, its use is promoted in medical litera-
ture, including a very recent and lengthy series of
nephrology-specific articles [12–16].
Taken together, this indicates there may be a contra-
diction between what we do and promote through
research to achieve best outcomes and what we do and
promote in “real-life” to actually realize them. CQI
efforts in nephrology should be published so that we can
learn from others about how these tools work and which
ones provide the most benefits. This review serves as a
starting point to better understand these areas. But as
with prior evaluations in other aspects of healthcare
point out, [17, 19] a challenge remains for future studies
using CQI; not only to report on how CQI has been
implemented, but to acknowledge and address when
changes do occur, that they occur because of CQI
attributes and not because of other factors.
Another reason for paucity of reporting on CQI efforts
in research or other literature may be that tools within
CQI have not fully caught on with practitioners or
researchers in the nephrology community. As stated
above, this may change because there are a growing num-
ber of recent publications promoting its use [39, 40].
Moreover, CMS has promoted a focus on quality and
performance measurements (i.e., quality metrics) to evalu-
ate care and practice in ESRD for some time [20, 41]. This
foundational work in the 1990’s and early 2000’s
related to evaluation of quality initiatives in ESRD
populations [21–24] may be the reason for our obser-
vation of a preponderance of studies in dialysis popu-
lations more recently.
But CQI can provide more than a basis to evaluate
metrics in a focused area of one medical discipline. CQI
offers tools to address problems and optimize processes
across disparate areas of disease management. It can
provide a foundation for culture and paradigm changes
that support and sustain improvements, across the con-
tinuum of kidney care, even prior to renal replacement
(Table 3).
There are potential limitations of this review. As in all re-
views, there is risk for incomplete retrieval of all studies on
topic-in this case CQI within nephrology. We attempted to
minimize this risk by using broad and inclusive search cri-
teria with multiple terms that encompassed both CQI and
nephrology, spanning over ten years. We also applied our
search outside of usual sources and into the gray literature,
recognizing that non-traditional distribution channels may
be more amenable to reporting on CQI efforts. Another
limitation is that there is not one recognized and singular
definition for CQI nor for what is deemed “CQI research”.
We attempted to address this in several meetings of our
expert panel to unify our approach and definitions, clarify
potential relevant search terms and create a review proto-
col which we pilot-tested and then revised for clarity prior
to the full review.
There are several important implications of this review.
Only 19 of the 76 studies focused on pre-dialysis CKD
with only four occurring in patients where kidney disease
strikes early (pediatrics). With the majority of studies
focused on end stages, clearly there remains a need to shift
an equal if not larger focus from research in tertiary pre-
vention to primary and secondary prevention [42]. There
may also be a need to expand current efforts to educate
those within nephrology research on CQI tools and how
they can be applied across the spectrum of disease, a
process in its infancy. With the majority of publications
arising from North America, there may be opportunity to
promote CQI education not only in U.S. nephrology train-
ing, but across the globe. Although there are some metrics
established related to ESRD performance, we need more
than metrics to effect the changes necessary to improve
overall health in our populous. Lastly, as non-
Table 3 Quality assurance vs continuous quality improvement adapted and reprinted from U.S. Department of Health and Human
Services, HRSA, “What is the difference between quality improvement and quality assurance?” 3/18/15
Quality assurance Continuous quality improvement
Motivation Measuring compliance with standards Continuously improving processes to meet standards
Means Inspection Prevention
Attitude Required, defensive Chosen, proactive
Focus Outliers: "bad apples" Individuals Processes Systems
Scope Medical provider Patient care
Responsibility Few All
[http://www.hrsa.aquilentprojects.com/healthit/toolbox/HealthITAdoptiontoolbox/QualityImprovement/whatarediffbtwqinqa.html]
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traditional research efforts expand, areas of research
like implementation science (“(the) study of methods
to promote…systematic uptake of research findings
and other evidence-based practices into routine practice”
[43] may lead to more reporting of CQI related
studies [44].
Conclusions
To our knowledge this is the first systematic review of
the published literature to determine how CQI has been
applied to optimize outcomes in nephrology. We found
that although there are CQI applications reported, the
majority of studies mainly focused at end stages of
disease, with comparison outcomes assessed just over
half the time. There remains a significant and missed
opportunity to examine CQI effectiveness and impact on
outcomes, potentially as a way to usher in the sweeping
improvement that is needed to address the gap between
low quality and high cost seen in many chronic diseases
including CKD.
Additional file
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